VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GYROGyrodyne, LLC
$6.23$14M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksGYROFinancials

Gyrodyne, LLC (GYRO) Financials

26Y historyFree accessUpdated daily

Revenue performance remains highly intermittent, with the company recording revenue in only one of the last ten reported quarters, while fixed SG&A costs of $8.1K in 2023Q1 continue to drag on net asset value.

GYRO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Apr'06Apr'05Apr'04Apr'02Apr'01Apr'00Apr'99Apr'98Apr'97Apr'96Apr'95Apr'94Apr'93Apr'92
Sales/Revenue2.8M0001.82M4.95M5.03M4.99M5.52M5.55M4.83M3.09M2.92M1.63M2.04M2.09M2.61M2.45M2.33M2.2M2.2M2.1M2.6M1.7M1.6M2.6M1.5M
Revenue Growth %----100%-63.12%-1.61%0.82%-9.62%-0.56%14.83%56.34%5.96%79.35%-20.21%-2.3%-19.98%6.62%5.11%5.77%0%4.76%-19.23%52.94%6.25%-38.46%73.33%-
Cost of Goods Sold11.05K0001.6M2.61M2.52M2.31M2.35M2.22M1.94M1.23M896.34K447.06K733.54K513.41K594.01K658.57K753K700K1.2M1.4M1.3M1.1M1.1M1.8M1M
COGS % of Revenue----87.56%52.66%50%46.26%42.52%39.97%40.19%39.62%30.72%27.48%35.98%24.6%22.78%26.92%32.36%31.82%54.55%66.67%50%64.71%68.75%69.23%66.67%
Gross Profit2.79M000501.06K2.34M2.52M2.68M3.17M3.33M2.89M1.87M2.02M1.18M1.31M1.57M2.01M1.79M1.57M1.5M1M700K1.3M600K500K800K500K
Gross Margin %99.61%---27.46%47.34%50%53.74%57.46%60.03%59.81%60.35%69.29%72.53%64.05%75.37%77.22%73.34%67.64%68.18%45.45%33.33%50%35.29%31.25%30.77%33.33%
Gross Profit Growth %----100%-78.61%-6.84%-6.19%-15.48%-4.8%15.25%54.94%-7.72%71.36%-9.65%-16.97%-21.9%12.26%13.98%4.93%50%42.86%-46.15%116.67%20%-37.5%60%-
Operating Expenses2.39M-5K-5K-6K4.22M5.36M15.14M158.9K3.17M3.17M4.82M2.91M3.98M2.64M2.09M1.89M2.02M1.76M1.99M1.5M1.4M1.3M1.1M900K1M600K500K
OpEx % of Revenue----231.3%108.28%300.98%3.18%57.46%57.18%99.75%94.11%136.29%162.51%102.35%90.51%77.51%72.16%85.56%68.18%63.64%61.9%42.31%52.94%62.5%23.08%33.33%
Selling, General & Admin2.39M-3K-4K-5K4.22K4.39M15.19M7.58M1.89M2.26M4.13M2.55M3.33M2.33M1.75M1.59M1.42M1.19M1.5M1M1.3M1.2M900K700K800K500K500K
SG&A % of Revenue----0.23%88.68%301.97%151.83%34.28%40.73%85.48%82.5%114.19%143.21%86.03%76.02%54.62%48.81%64.63%45.45%59.09%57.14%34.62%41.18%50%19.23%33.33%
Research & Development0--------------------------
R&D % of Revenue---------------------------
Other Operating Expenses0--------------------------
Operating Income-33.4K5K5K6K-2.31M-3.03M-15.73M-5.79M404.35K157.9K-1.93M-1.04M-1.96M-1.46M-781K-315K-7.47K94.54K-417K-7K-400K-600K200K-300K-500K200K-600K
Operating Margin %-1.19%----126.74%-61.26%-312.66%-116.14%7.33%2.84%-39.95%-33.76%-67.03%-89.98%-38.3%-15.09%-0.29%3.87%-17.92%-0.32%-18.18%-28.57%7.69%-17.65%-31.25%7.69%-40%
Operating Income Growth %-0%-16.67%100.26%23.71%80.72%-171.44%-1532.9%156.09%108.18%-84.96%46.63%-33.61%-87.45%-147.94%-4115.74%-107.9%122.67%-5857.14%98.25%33.33%-400%166.67%40%-350%133.33%-
EBITDA176.21K166.14K57.52K28.82K-2.05M-2.06M-14.73M-4.61M1.32M1M-1.22M-662.76K-1.79M-1.36M-665.39K-195.06K112.86K204.21K-309K93K-300K-500K400K-100K-300K300K-600K
EBITDA Margin %6.3%----112.54%-41.67%-292.78%-92.34%23.82%18.08%-25.31%-21.43%-61.39%-83.47%-32.63%-9.35%4.33%8.35%-13.28%4.23%-13.64%-23.81%15.38%-5.88%-18.75%11.54%-40%
EBITDA Growth %103.59%188.86%99.6%101.4%0.4%86%-219.67%-450.33%31.05%182.03%-84.57%63%-31.9%-104.11%-241.13%-272.83%-44.73%166.09%-432.26%131%40%-225%500%66.67%-200%150%-
D&A (Non-Cash Add-back)209.61K161.14K52.52K22.82K259.2K969.57K1M1.19M910.68K845.6K707.75K381.24K164.59K105.86K115.61K119.94K120.33K109.67K108K100K100K100K200K200K200K100K0
EBIT0000-2.9M-2.92M-15.49M161.66M72.74K159.29K-1.66M-488K-1.79M-1.46M-781K-315K-7.47K28.59K-417K-7K-400K-600K200K-300K-500K200K0
Net Interest Income00000-639K231.21K66.46M-1.2M-1.13M-836K90.09K-162K1.08M67.64K72.87K-12.55K-25.37K-26K-100K-100K-100K-100K00-100K0
Interest Income0000766.35K110.31K236.95K67.43M1.7K1.4K107.32K556.06K1.04M1.08M102.85K111.72K48.97K40.59K45K00000000
Interest Expense0--------------------------
Other Income/Expense0--------------------------
Pretax Income0000-2.82M-4.28M-15.5M160.7M-1.13M-972K-2.61M-954K-1.96M21.47M-229K-204K20.18K1.07M-14K300K-500K-600K300K-800K-600K100K500K
Pretax Margin %0%----154.74%-86.46%-308.11%3221.03%-20.38%-17.51%-53.93%-30.85%-67.03%1319.42%-11.23%-9.77%0.77%43.91%-0.6%13.64%-22.73%-28.57%11.54%-47.06%-37.5%3.85%33.33%
Income Tax000085K-565K-61.55M61.65M0109K-4.13M-2.5M-404K8.35M-91.77K-90.24K-1.47K378.71K-12K100K-200K-200K200K-200K-200K100K200K
Effective Tax Rate %-----3.01%13.2%397.17%38.36%0%-11.21%158.42%261.64%20.65%38.91%40.07%44.23%-7.26%35.26%85.71%33.33%40%33.33%66.67%25%33.33%100%40%
Net Income0000-2.5M147.55K46.06M99.05M-1.13M-1.08M1.52M1.54M-1.55M13.12M-138K-113K21.64K695.76K-2K200K-300K-400K100K-600K-400K500K300K
Net Margin %0%----137.1%2.98%915.77%1985.33%-20.38%-19.47%31.51%49.87%-53.19%806.08%-6.77%-5.41%0.83%28.44%-0.09%9.09%-13.64%-19.05%3.85%-35.29%-25%19.23%20%
Net Income Growth %---100%-1795.66%-99.68%-53.49%8904.27%-4.07%-170.98%-1.23%199.36%-111.83%9603.62%-22.12%-622.06%-96.89%34888.15%-101%166.67%25%-500%116.67%-50%-180%66.67%-
Net Income (Continuing)0000-2.91M-3.71M46.05M99.05M-1.13M-1.08M1.52M1.54M-1.55M13.12M-138K-113K21.64K695.76K-2K200K-300K-400K100K-600K-400K0300K
Discontinued Operations000000000000000000000000000
Minority Interest0000015.81M18.63M00000000000000000000
EPS (Diluted)-0.000.000.00-1.691.11343.69738.94-9.29-9.2713.0513.27-13.38113.83-1.29-1.110.226.190.222.21-2.89-3.821.21-6.10-3.824.933.42
EPS Growth %---100%-252.25%-99.68%-53.49%8054.14%-0.22%-171.03%-1.66%199.18%-111.75%8924.03%-16.22%-604.55%-96.45%2713.64%-90.05%176.47%24.35%-415.7%119.84%-59.69%-177.48%44.15%-
EPS (Basic)-0.000.000.00-1.691.11343.69738.94-9.29-9.2713.0513.27-13.41118.03-1.29-1.110.226.310.222.21-2.89-3.971.21-6.10-3.824.933.42
Diluted Shares Outstanding1.48M1.48M1.48M1.48M1.48M134.03K134.03K134.03K121.2K116.62K116.62K116.62K115.7K115.17K106.71K102.5K110.78K112.02K109.87K107.07K103.84K104.68K99.19K98.34K104.68K101.48K87.75K
Basic Shares Outstanding1.48M1.48M1.48M1.48M1.48M148.42K134.03K134.03K121.2K116.62K116.62K116.62K115.7K111.15K106.71K102.5K110.11K111.15K109.87K106.83K103.84K100.65K99.19K98.34K104.68K101.48K87.75K
Dividend Payout Ratio------147.61%57.33%------------------66.67%

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Protracted Regulatory Entitlement Delays

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2023Q1)

Liquidation Strategy Obscures Revenue Trends

As indicated by historical financial filings, Gyrodyne's top-line performance remains highly intermittent, with revenue appearing in only one of the last ten reported quarters, reflecting a business model that has shifted away from recurring operations toward the sporadic, project-based disposition of its remaining real estate assets.

The absence of consistent revenue generation suggests that the company is no longer functioning as a traditional operating entity. Investors should interpret the lack of top-line growth as a direct consequence of the transition to a liquidation-focused strategy rather than a failure of commercial demand.

Fixed G&A Burden Erodes Value

Based on reported quarterly figures, the company consistently incurs SG&A expenses despite minimal revenue, which suggests that the ongoing costs of maintaining a public listing and pursuing complex zoning entitlements are creating a persistent drag on the net asset value available for eventual shareholder distribution.

The recurring nature of these administrative costs, even in periods without revenue, highlights the structural inefficiency of the current corporate shell. This expense profile warrants close monitoring, as the duration of the entitlement process directly correlates with the erosion of the company's remaining capital base.

Accounting Shift Renders Earnings Obsolete

According to recent SEC filings, the company's adoption of the liquidation basis of accounting renders traditional metrics like net income and EPS effectively meaningless, as these figures fail to capture the fair value adjustments of the underlying real estate assets held for sale in New York.

Analysts should disregard standard income statement profitability metrics, as they do not reflect the economic reality of the liquidation process. The focus must instead shift toward the net realizable value of the land parcels, as reported in the statement of changes in net assets.

Regulatory Risks Threaten Terminal Value

As noted in regulatory disclosures, the company's reliance on successful zoning outcomes in St. James and Cortlandt Manor creates a binary risk profile where any further regulatory delays could significantly impair the terminal value of the assets and extend the period of cash-burning administrative overhead.

The market's valuation of the company appears to hinge on the successful conversion of land use, which remains subject to the unpredictable nature of local New York municipal approvals. Investors should consider that the longer the entitlement process persists, the greater the risk that professional fees will consume a larger portion of the final liquidation proceeds.

GYRO — Frequently Asked Questions

Quick answers to the most common questions about buying GYRO stock.

What was Gyrodyne, LLC's (GYRO) revenue in 2018?

For fiscal year 2018, Gyrodyne, LLC (GYRO) reported total revenue of $0.0M. This represents a 100.0% decline compared to $1.5M in 1991.

Is Gyrodyne, LLC (GYRO) profitable?

Gyrodyne, LLC (GYRO) reported a net loss of $0.0M for the fiscal year ending 2018.